Matthew K. Szot, Chief Financial Officer at Cadrenal Therapeutics, Inc. (CVKD), sold 2,000 shares at $14.00 ($28K) on 2025-08-27, disclosed to the SEC on 2025-08-29.
Open-market sale of $28k CVKD by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.00 | 1,600 | $22K | 80.0% |
| 2 | $14.00 | 400 | $6K | 20.0% |
| Total | $14.00 avg | 2,000 | $28K | 100% |
| Filing → |
| SNES | SELL | 2025-11-17 | $3 | — | Filing → |
| CVKD | SELL | 2025-10-28 | $50K | — | Filing → |
| CVKD | SELL | 2025-10-14 | $49K | — | Filing → |